Despite the substantial burden of HF in kidney transplant recipients, the exclusion of this population from clinical trials raises concerns about the safety and efficacy of GDMT in these patients.
What are the concerns and how can they be overcome?
👉https://buff.ly/172WzvE
#CardioSky
www.springermedicine.com
Despite the substantial burden of heart failure in kidney transplant recipients, the exclusion of this population from clinical trials raises concerns about the safety and efficacy of GDMT in these…